User profiles for Ronnie Mease
Ronnie MeaseAssociate Professor, Johns Hopkins University Verified email at jhmi.edu Cited by 8966 |
[HTML][HTML] Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer
…, H Fan, RF Dannals, Y Chen, RC Mease… - Molecular imaging and …, 2015 - Springer
Purpose Prostate-specific membrane antigen (PSMA) is a recognized target for imaging
prostate cancer. Here we present initial safety, biodistribution, and radiation dosimetry results …
prostate cancer. Here we present initial safety, biodistribution, and radiation dosimetry results …
2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate …
Purpose: We have synthesized and evaluated in vivo 2-(3-{1-carboxy-5-[(6-[ 18 F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic
acid, [ 18 F]DCFPyL, as a potential …
acid, [ 18 F]DCFPyL, as a potential …
Radiolabeled Small-Molecule Ligands for Prostate-Specific Membrane Antigen: In vivo Imaging in Experimental Models of Prostate Cancer
Purpose: Prostate-specific membrane antigen (PSMA) is a cell surface protein that is
overexpressed in prostate cancer, including hormone-refractory and metastatic disease. Our goal in …
overexpressed in prostate cancer, including hormone-refractory and metastatic disease. Our goal in …
Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with …
SY Cho, KL Gage, RC Mease… - Journal of Nuclear …, 2012 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA) is a type II integral membrane protein
expressed on the surface of prostate cancer (PCa) cells, particularly in androgen-independent, …
expressed on the surface of prostate cancer (PCa) cells, particularly in androgen-independent, …
Synthesis and evaluation of technetium-99m-and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA)
…, CA Foss, M Castanares, RC Mease… - Journal of medicinal …, 2008 - ACS Publications
The prostate-specific membrane antigen (PSMA) is increasingly recognized as a viable target
for imaging and therapy of cancer. We prepared seven 99m Tc/Re-labeled compounds by …
for imaging and therapy of cancer. We prepared seven 99m Tc/Re-labeled compounds by …
N-[N-[(S)-1,3-Dicarboxypropyl]Carbamoyl]-4-[18F]Fluorobenzyl-l-Cysteine, [18F]DCFBC: A New Imaging Probe for Prostate Cancer
RC Mease, CL Dusich, CA Foss, HT Ravert… - Clinical Cancer …, 2008 - AACR
Purpose: Previously, we showed successful imaging of xenografts that express the prostate-specific
membrane antigen (PSMA) using small-animal positron emission tomography (PET) …
membrane antigen (PSMA) using small-animal positron emission tomography (PET) …
68Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer
Gallium-68 is a generator-produced radionuclide for positron emission tomography (PET)
that is being increasingly used for radiolabeling of tumor-targeting peptides. Compounds [ 68 …
that is being increasingly used for radiolabeling of tumor-targeting peptides. Compounds [ 68 …
Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer
To extend our development of new imaging agents targeting the prostate-specific
membrane antigen (PSMA), we have used the versatile intermediate 2-[3-(5-amino-1-carboxy-pentyl)-…
membrane antigen (PSMA), we have used the versatile intermediate 2-[3-(5-amino-1-carboxy-pentyl)-…
PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer
…, H Fan, RF Dannals, Y Chen, RC Mease… - Molecular imaging and …, 2016 - Springer
Purpose Current standard of care conventional imaging modalities (CIM) such as X-ray
computed tomography (CT) and bone scan can be limited for detection of metastatic prostate …
computed tomography (CT) and bone scan can be limited for detection of metastatic prostate …
PET imaging in prostate cancer: focus on prostate-specific membrane antigen
Prostate cancer (PCa) is the second leading cause of cancer-related death in American men.
Positron emission tomography/computed tomography (PET/CT) with emerging …
Positron emission tomography/computed tomography (PET/CT) with emerging …